What’s in the pipeline for emerging Bay Area cell and gene therapy startups?

According to a March 30 report from the Alliance for Regenerative Medicine, nearly $20 billion of investment flowed into biotech companies developing cell-, gene- and tissue-based therapies last year, more than double the figure from the previous year.